This study aimed to define the clinical characteristics, treatment outcome and independent prognostic factors of 144 patients with T-and 357 B-cell non-Hodgkin's lymphomas. Entities with well-defined immunophenotype and clinical characteristics were excluded. Patients with T-cell tumours were younge
Telomerase activity in B-cell non-Hodgkin lymphoma
โ Scribed by Scott A. Ely; Amy Chadburn; C. Mitchell Dayton; Ethel Cesarman; Daniel M. Knowles
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 144 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Background:
Studies have shown telomerase activity to be present in some b-cell non-hodgkin lymphomas (b-nhls). however, no large studies have assayed telomerase activity in a systematic and quantitative manner. furthermore, the relation between telomerase and proliferation suggested by in vitro studies has not been adequately tested in b-nhls in vivo. this information is necessary to understand the relation between proliferation and telomerase and to predict the efficacy of antitelomerase drugs currently in development.
Methods:
Eighteen benign biopsies and 111 b-nhls of varying types were classified according to the revised european-american classification of lymphoid neoplasms (real classification) and assayed for telomerase activity and proliferation index (pi).
Results:
All b-nhls contained telomerase activity except for low grade marginal zone b-cell lymphomas (mzbcls) (96 of 111, 86%) (chi(2) 95.90, p < 0.001). telomerase activity correlated with pi (r = 0.7536, r(2) = 0.5678, t = 10.51, p < 0.001) and showed a threshold whereby telomerase activity was not present below a pi of 9.2% (t = 4.875, p < 0.001).
Conclusions:
The level of telomerase activity fell within characteristic ranges and generally correlated with the clinical aggressiveness of each b-nhl category. low grade mzbcls of extranodal, nodal, and splenic types were unique among the categories of b-nhl in lacking or containing very little telomerase activity. the association between telomerase activity and pi is evidence that telomerase is controlled in vivo along with the cell cycle and is not constitutively active in b-nhl. these data provide evidence that antitelomerase drugs may be efficacious in most types of b-nhl.
๐ SIMILAR VOLUMES
A standard Philadelphia translocation, t(9;22) (q34;qll), was found In lymph node cells from a patient with non-leukemic non-Hodgkln lymphoma at the time of diagnosis. The rearrangement of the breakpoint cluster region (bcr) was not detected with a bcr-3' probe, The neoplastic clone was of monoclona
## BACKGROUND. Telomerase activity has been shown to be increased in numerous tumors and cell lines, although to the authors' knowledge there has been no previous assessment of telomerase activity in renal cell carcinoma (RCC). To examine whether telomerase activity could be used as a biochemical p
The PTEN gene is involved in 10q23 deletions in several types of cancer, including glioma, melanoma, endometrial and prostate carcinomas. The PTEN gene product is a dual-specificity phosphatase with putative tumor suppressor function. Deletions and rearrangements of 10q22-25 have been reported in ฯณ5
## Background and Objectives: The spleen is frequently involved in patients with non-Hodgkin lymphoma (NHL). The indications for splenectomy in this disease include amelioration of symptoms from splenomegaly, correction of cytopenias, and the need to establish the diagnosis. The aim of this study
Non-Hodgkin's lymphoma associated with pregnancy is rare. To date, only 1 case in which lymphoma was diagnosed and treated during pregnancy, with normal pregnancy outcome, has been reported. We describe another case where life-threatening, diffuse, poorly differentiated lymphocytic lymphoma was diag